tykhr
sign in
free sign up
Cyclacel Pharmaceuticals Inc
Biotechnology
Healthcare
CYCCP
12.96 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.50
52 week high
11.40
high
6.60
52 week low
0.00
low
6.00
growth
-14.29 %
previous Close
7.21
P/E ratio
market cap
10.36 M
div yield
0
usd
Jun 2021
qoq
revenue
0.00 %
net incoming
-5.13 M
-47.41 %
eps
0.00 %
4.08 %
eps surprise
0.00 %
net profit margin
-512700000.00 %
0.00 %
operating incoming
-6.10 M
-41.70 %
net change in cash
-4.14 M
-128.79 %
cash on hand
43.64 M
-8.66 %
cost of revenue
17.00 K
88.89 %
top